World-first Proton Pencil Beam Scanning System with FDA Clearance



Similar documents
HITACHI Proton Beam Therapy System

Proton beam. Medical Technical Complex Joint Institute for Nuclear Research, Dubna, Russia

Feasibility Study of Neutron Dose for Real Time Image Guided. Proton Therapy: A Monte Carlo Study

Development of on line monitor detectors used for clinical routine in proton and ion therapy

Overview of Proton Beam Cancer Therapy with Basic Economic Considerations

Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.

Current Status and Future Direction of Proton Beam Therapy

FOR IMMEDIATE RELEASE

How To Use A Proton For Radiation Therapy

Medical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza

Basic Radiation Therapy Terms

A Patient s Guide to the Calypso System for Breast Cancer Treatment

Proton Radiotherapy. Cynthia Keppel Scientific and Technical Director Hampton University Proton Therapy Institute. Lead Virginia.

Secondary Neutrons in Proton and Ion Therapy

Manual for simulation of EB processing. Software ModeRTL

Cyclotron Centre in Poland and 2D thermoluminescence dosimetry

MODELING AND IMPLEMENTATION OF THE MECHANICAL SYSTEM AND CONTROL OF A CT WITH LOW ENERGY PROTON BEAM

AMERICAN BRAIN TUMOR ASSOCIATION. Proton Therapy

Joint Application of Perl Scripts and MCNPX in Solving the Dynamic-Geometry Related Problems in Proton Beam Radiotherapy

Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA

Development of Radiation Resistant Quadrupoles Based on High Temperature Superconductors for the Fragment Separator

PROTON THERAPY FREQUENTLY ASKED QUESTIONS

ACCELERATORS AND MEDICAL PHYSICS 2

Optiffuser. High-performance, high bandwidth lightweight 1D diffuser.

Advanced Radiation Therapy of Cancer by Proton Beam

Proton Therapy. What is proton therapy and how is it used?

Clinical Physics. Dr/Aida Radwan Assistant Professor of Medical Physics Umm El-Qura University

The accurate calibration of all detectors is crucial for the subsequent data

How To Treat Cancer With Proton Therapy

AUTOMATION OF OPERATIONS ON THE VEPP-4 CONTROL SYSTEM

Proton Therapy in Singapore

In 1946 Harvard physicist Robert Wilson ( ) suggested:

Tom Wilson Product Marketing Manager Delivery Systems Varian Medical Systems International AG. CERN Accelerator School, May 2015

CONQUERING CANCER SAVING LIVES. Mayo Clinic Proton Beam Therapy Program

ATOMS: ATOMIC STRUCTURE QUESTIONS AND ANSWERS

Use of 3D Printers in Proton Therapy

. Tutorial #3 Building Complex Targets

Production of X-rays. Radiation Safety Training for Analytical X-Ray Devices Module 9

Technology for Next-generation Reduced-size High-performance Inverter

The Science behind Proton Beam Therapy

FAQ About Prostate Cancer Treatment and SpaceOAR System

DEMONSTRATION ACCELERATOR DRIVEN COMPLEX FOR EFFECTIVE INCINERATION OF 99 Tc AND 129 I

Performance Improvement of Pump-turbine for Large Capacity Pumped Storage Power Plant in USA

Encoders for Linear Motors in the Electronics Industry

HADRON THERAPY FOR CANCER TREATMENT

Intensity-Modulated Radiation Therapy (IMRT)

A Compact Linac for Proton Therapy Based on a Dielectric Wall Accelerator

Hitachi Healthcare Company - Our Strategy and Opportunities -

THE POWER AND PRECISION OF PROTON BEAM THERAPY IS WITHIN REACH

PHYS 222 Spring 2012 Final Exam. Closed books, notes, etc. No electronic device except a calculator.

Use of the VALIDATOR Dosimetry System for Quality Assurance and Quality Control of Blood Irradiators

Quality Assurance of Radiotherapy Equipment

Radiation Therapy for Prostate Cancer

UNIVERSITY OF SASKATCHEWAN Department of Physics and Engineering Physics

Cathode Ray Tube. Introduction. Functional principle

Interference. Physics 102 Workshop #3. General Instructions

In the previous presentation, we discussed how x-rays were discovered and how they are generated at the atomic level. Today we will begin the

Reduction of Electron Contamination Using a Filter for 6MV Photon Beam

LOMA LINDA UNIVERSITY MEDICAL CENTER PROTON TREATMENT AND THE CONTROL OF CANCER

The Therac 25 A case study in safety failure. Therac 25 Background

First Three Years After Project Proton Therapy Facility:

Proton therapy, yesterday, today and tomorrow

Prostate Cancer. Treatments as unique as you are

FDTD Analysis of Site Free Space VSWR in Test Site Used for Disturbance Measurement above 1 GHz

Mission: Cure, Research and Teaching. Marco Pullia Cnao design and commissioning

Prostate Cancer Guide. A resource to help answer your questions about prostate cancer

APA format (title page missing) Proton Therapy 3. A paper. A New Cancer Treatment: Proton Therapy. A Review of the Literature

PHOTOELECTRIC EFFECT AND DUAL NATURE OF MATTER AND RADIATIONS

Ferroxcube. For more information on Product Status Definitions, see page Sep CBW625

Therapy with protons and ion beams

AS COMPETITION PAPER 2008

C.-K. Ng. Stanford Linear Accelerator Center. and. T. Weiland. University oftechnology. FB18, Schlossgartenstr. 8. D64289, Darmstadt, Germany.

WELCOME. Massachusetts General Hospital Cancer Center

Industrial tracers - Finding leaks and blockages

Use the following image to answer the next question. 1. Which of the following rows identifies the electrical charge on A and B shown above?

Cancer Therapy with Particle Beams

Design and Scheduling of Proton Therapy Treatment Centers

Information about the T9 beam line and experimental facilities

IBA Proton Therapy. Biomed days Vincent Bossier. System Architect Protect, Enhance and Save Lives

Applications of New, High Intensity X-Ray Optics - Normal and thin film diffraction using a parabolic, multilayer mirror

E. K. A. ADVANCED PHYSICS LABORATORY PHYSICS 3081, 4051 NUCLEAR MAGNETIC RESONANCE

Comments on the Draft Report by the California Council on Science and Technology Health Impacts of Radio Frequency from Smart Meters

Development and Experimental Performance Evaluation of a Dose-Rate meter for Pulsed Beam.

CHAPTER 2 INJECTION MOULDING PROCESS

In-situ Load Testing to Evaluate New Repair Techniques

NIA RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning

Potential Benefits of Proton Therapy in Clinic

Laser drilling up to15,000 holes/sec in silicon wafer for PV solar cells

How To Know If You Are Safe To Use An Antenna (Wired) Or Wireless (Wireless)

ELECTRONIC MEDICAL RECORDS (EMR) STREAMLINE CH I PROCESS. Ping Xia, Ph.D. Head of Medical Physics Department of Radiation Oncology Cleveland Clinic

3D SCANNERTM. 3D Scanning Comes Full Circle. s u n. Your Most Valuable QA and Dosimetry Tools A / B / C. The 3D SCANNER Advantage

Powder diffraction and synchrotron radiation

THE ALIGNMENT STRATEGY FOR THE SPIRAL2 SUPERCONDUCTING LINAC CRYOMODULES

Gamma-ray Large Area Space Telescope (GLAST) Large Area Telescope (LAT) Calorimeter AFEE Board Parts Radiation Test Plan

Transcription:

Hitachi Review Vol. 58 (29), No.5 225 World-first Proton Pencil Beam Scanning System with FDA Clearance Completion of Proton Therapy System for MDACC Koji Matsuda Hiroyuki Itami Daishun Chiba Kazuyoshi Saito, Dr. Eng. OVERVIEW: The proton therapy facility constructed by Hitachi at the M. D. Anderson Cancer Center in Texas in the USA has been completed and the four treatment rooms are now in use. Proton therapy has attracted attention as a form of radiotherapy that can concentrate irradiation dose on the tumor with minimal effect on the surrounding healthy tissue. Use of scanning irradiation systems, which represent the latest technology, is expected to improve the quality of treatment and therefore plans are in progress around the world to install these systems. The facility described here commenced its scanning irradiation treatment on May 19 28, making it the first in the world to use a commercial scanning system with FDA clearance. INTRODUCTION PROTON therapy is a form of cancer radiotherapy. Protons accelerated to high energy by an accelerator pass through the treatment device and are applied to the patient. Demand for proton therapy has been growing in recent years because of its ability to target (b) (a) (c) Fig. 1 Overview of Proton Therapy Facility at M. D. Anderson Cancer Center (MDACC) (left), Rotating Gantry Treatment Room (top right), and Synchrotron Accelerator (bottom right). An overview of the proton therapy facility at the M. D. Anderson Cancer Center is shown on the left. The facility consists of an underground synchrotron accelerator (bottom right) and four treatment rooms where the proton beam generated by the accelerator is used for treatment. The equipment was manufactured and commissioned by Hitachi, with the work being completed in September 28.

World-first Proton Pencil Beam Scanning System with FDA Clearance 226 the location of the cancer, resulting in fewer side effects compared to previous radiotherapy treatment methods that use X-rays. As of fall 28, proton therapy systems were in use at six sites in Japan and 21 sites outside Japan. There are also a number of plans in progress for the construction of new facilities in the world. Applying accelerator technology acquired by joining various accelerator project for research use, Hitachi was amongst the first to start developing proton therapy systems (1),(2). This has included supplying a multipurpose accelerator system (3) to The Wakasa Wan Energy Research Center and a proton therapy system (4) to the Proton Medical Research Center at the University of Tsukuba. In December 22, an order for a proton therapy system was received from the M.D. Anderson Cancer Center (MDACC), one of the world s leading cancer treatment centers, and the system was handed over after commissioning of all equipment was complete in September 28. The proton therapy system at MDACC consists of one scanning and three scattering treatment units. This article focuses on the scanning irradiation system in particular as it represents the leading edge of current technology. PROTON CANCER THERAPY Features of Proton Cancer Therapy Proton cancer therapy uses a high-energy proton beam formed of protons accelerated up to 4 to 6% of the speed of light (corresponding to energies of 7 to 25 MeV). Fig. 2 shows a graph comparing the dose distribution relative to depth into the body for protons with that for the X-rays used by previous radiotherapy techniques. The higher the dose, the greater the energy absorbed by the body tissue and the more cells are killed. Accordingly, effective radiotherapy can be achieved if the dose can be concentrated on the tumor to destroy the cancer cell while minimizing the dose in regions away from the tumor so as to keep side effects to a minimum. Whereas the intensity of X-rays falls gradually with the distance from the surface of the body, a characteristic of protons is that the dose has a peak where it delivers a high level of energy at a location deep in the body. This is called the Bragg peak. Because the depth in the body at which the Bragg peak occurs can be adjusted by controlling the energy of the proton beam, this allows the proton beam to be targeted at the tumor. Absorbed dose (absorbed energy) X ray Proton Bragg peak Tumor Depth Fig. 2 Comparison of Absorbed Dose Distributions Relative to Depth for Proton Beams and X-rays. A graph compares the absorbed dose distribution relative to depth into the body for proton beams and X-rays. The proton beam provides effective radiation treatment because it can be concentrated on a tumor located deep in the body. Proton Therapy Techniques Techniques for irradiation can be broadly divided into scattering and scanning methods. Fig. 3 shows the configuration of machines used for scattering and scanning respectively. The scattering method uses a scatterer consisting of a metal plate to spread the narrow beam generated by an accelerator then passes the beam through a hole in a collimator to form the target shape. In the depth direction, range modulating device expands and adjusts the energy distribution of the proton beam to form a region of uniformly high-dose region called an SOBP (spread out Bragg Beam (single energy) Range modulation Lateral spreading Collimator range compensator (a) High dose region Beam (variable energy) Scanning magnets Target (tumor) Patient body (cross section) Fig. 3 Comparison of Equipment Configurations for Scattering and Scanning Methods. In the scattering method (a), the beam, which spreads in the lateral and depth directions, is formed into the target shape laterally. In the scanning method (b), the beam is scanned in a three-dimensional pattern by the electromagnet and accelerator. (b)

Hitachi Review Vol. 58 (29), No.5 peak). Finally, a range compensator is used to form this high-dose region into the shape of the deepest part of the target. Because the thickness in the depth direction of the high-dose region formed by the scattering method (the SOBP width) is constant and equal to the maximum thickness of the target, it extends into the healthy tissue outside the tumor. In the scanning method, the narrow beam from the accelerator is scanned over the three-dimensional target region. The target region is scanned threedimensionally by using two scanning magnets to adjust the beam in the directions perpendicular to the beam direction and by progressively varying the accelerator energy to control the depth. In this way, a high-dose region is formed that matches the target shape. Fig. 4 shows example calculations of dose distribution for the scattering and scanning methods. This shows how the high-dose region (the region shown in red) formed by the scanning method is a better fit to the target shape (shown by the yellow line) than the scattering method. The scattering method also requires a collimator and range compensator to be prepared for each irradiation field so that they can be matched to the shape of the patient s tumor and this carries the associated costs of manufacture, installation, and disposal. Because the scanning region produced by the scanning method is generated and set electronically in the form of operational setup data for the scanning magnets and accelerator, there are no components like the collimator or range compensator that need to be prepared individually for each irradiation field. Another advantage of scanning is that, because it does not use a scatterer or collimator, the level of secondary neutron production is minimized. High-dose region Dose 1 Target High-dose region Target (a) (b) Fig. 4 Comparison of Dose Distribution in Scattering and Scanning Methods. In the scattering method (a), the thickness of the high-dose region in the depth direction is constant and extends outside the target area. In the scanning method (b), the high-dose region is closely matched to the target area. Treatment room 1 (scattering) Treatment room 2 (scattering) 227 Accelerator system Treatment room 3 (scanning) Treatment room 4 (scattering) Experimental room 85 m Fig. 5 Bird s Eye View of MDACC Proton Therapy System. The facility uses a synchrotron as its beam source and has four treatment rooms and one experimental room. The treatment room with a rotating gantry uses the scanning method and the other treatment rooms use the scattering method. HITACHI SCANNING IRRADIATION SYSTEM Configuration of Proton Therapy System at MDACC The MDACC is the largest cancer treatment center in the USA. Fig. 5 shows a bird s eye view of the proton therapy system. The facility consists of four treatment rooms and one experimental room. The proton beams for each room are supplied by a synchrotron accelerator system that has a 7-MeV linac as an injector. Protons accelerated up to a maximum of 25 MeV (6% of the speed of light) by the accelerator are delivered to the treatment rooms at a distance of several tens of meters away under the control of magnetic fields. The three treatment rooms closest to the accelerator have rotating gantry which allows the beam to be delivered to the patient from any direction (36 ). The scanning nozzle that is an irradiation instrument used for the scanning method is installed on the rotating gantry in treatment room 3 and the other treatment rooms use scattering nozzles. Scanning Nozzle The proton beam from the synchrotron travels via the high-energy beam transport line and gantry beam transport line to the scanning nozzle. Fig. 6 shows the configuration of the scanning nozzle used at the MDACC. The unit has a length of about 3 m. The beam is bent by two scanning magnets in the X and Y directions perpendicular to the incident beam to direct it at a point in a 3 cm 3 cm region. To reduce beam spread caused by scattering, the thickness of each device is kept as thin as possible. Similarly, to minimize scattering by air

World-first Proton Pencil Beam Scanning System with FDA Clearance 228 Proton beam Accumulated dose Target dose 2 Target dose 1 Position monitor Scanning magnets Scanning magnet current Setting 2 Setting 3 Time 3 m Helium chamber Beam intensity On Setting 1 Off On Off On Time Dose monitor (1, 2) Spot 1 Spot 2 Time Spot position monitor Fig. 6 Configuration of Scanning Nozzle. The nozzle is approximately 3 m long. The scanning magnets bend the beam to scan a two-dimensional region. The dose monitor controls the treatment dose and the two position monitors monitor the beam position. along the path of the beam, the beam passes through a sealed chamber filled with helium which has lower scattering effect. The beam size at high energies is approximately 5 mm. Two dose monitors measure the amount of passing through the parallel plate ionization chamber. One of these, called the main dose monitor, is used to control the dosage as explained in the following section. The other is called the sub-dose monitor and is used to monitor the dose. A beam position monitor located at the entrance of the nozzle and a spot position monitor located close to the irradiation surface measure the distribution of the passing beam in the multi-wire ionization chamber to check its position and size. Spot Irradiation Control The scanning method produces the desired dose distribution by using the beam to irradiate each individual small area (spot) within the target region with the appropriate dose for that spot. To irradiate a large number of spots in succession, a discrete spot scanning scheme is used whereby the beam is held in a fixed position while irradiating each spot and then turned off for the move to the next spot. As this technique does not move the beam to the next spot until it has confirmed that the current spot Fig. 7 Timing Chart for Spot Irradiation. The system uses the discrete spot scanning method whereby the beam is applied to a particular spot until the accumulated dose reaches the set value. The beam is then turned off while the current to the scanning magnets is changed. has received the required beam dosage, control of the dosage, beam position, and other parameters is relatively simple. Fig. 7 shows a timing chart for spot irradiation. The progress of spot irradiation is controlled based on the dosage measured by the dose monitor. When the accumulated dose reaches the set value, the beam off signal is output to turn off the beam for that spot. Next, the current to the scanning magnets is changed to reposition the beam to the next spot. After this change in current completes, the signal to turn the beam on again is output and irradiation starts for the next spot. The beam progresses through the spots one at a time with irradiation typically lasting for.5 to 5 ms per spot and movement between spots, including the various checks, taking approximate 3 ms. Turning the beam on and off is handled from the synchrotron by the fast beam switching technique described later. By repeating this process, irradiation is completed for all spots that require a particular energy and then the synchrotron acceleration is set to generate the proton beam at the next energy level and spot irradiation continues. Treatment of typical tumors completes in about one minute. Accelerator System The scanning method requires a high level of operational control of the accelerator system used to generate the beam based on the progress of spot

Hitachi Review Vol. 58 (29), No.5 229 irradiation. The following sections describe the features of the Hitachi synchrotron system that make this possible. (1) Beam extraction control The discrete spot scanning scheme requires highspeed beam on/off control and good stability for the beam position and size. The key technology for achieving this is RF (radio frequency) -driven extraction (5). The synchrotron beam follows a stable circulating orbit formed by a magnetic field. Beam extraction utilizes the phenomenon of resonance resulting from a nonlinear magnetic field created by sextupole magnets to destabilize a part of the beam so that it detaches from its circulating orbit and is gradually extracted to the outside of the synchrotron. Whereas the beam in conventional synchrotrons is extracted by controlling the electromagnets so that the unstable region of the beam gradually spreads, RF-driven extraction leaves the electromagnet settings constant and instead applies a high-frequency electric field so that the circulating beam gradually spreads, slowly forcing it out to the unstable region where the beam is extracted. The features of this technique are suited to the scanning method, not only because leaving the electromagnet settings unchanged keeps the position, size, energy, and other parameters for the extracted beam stable without any variations along with timeline, but also because functions such as high-speed beam on/off control and beam intensity control are easy to implement by controlling the power of the high-frequency electric field. (2) Energy scanning operation The operation cycle of the synchrotron is a repeating cycle of accelerating the injection beam from the injection linac and extracting the accelerated beam and then preparing for the next injection. Because the scanning method involves progressively changing the energy of the extracted beam, it is necessary to change the settings to those for the next required energy after each accelerationextraction cycle is over. Hitachi s synchrotron features an energy scanning operation whereby it can progressively step through a number of preset energies. The settings of the beam transport line that carries the beam to the irradiation units must also be changed to match the energy being used. Even when using energy scanning operation, this system can control the position of the beam at the irradiation units 6 m from the accelerator with an accuracy of +/-.5 mm. (3) Variable flat-top/variable cycle operation The number of spots to be irradiated with each energy depends on the tumor shape and can vary widely from a few spots up to a thousand spots. Typical synchrotrons cycle through their operation in a fixed time during which they produce an accelerated beam for a fixed time (from several hundred milliseconds to several seconds) and then prepare to accelerate the next beam. The time after the acceleration phase during which the beam is being produced is called the flat-top period. However, this fixed-cycle-time operation with a constant flattop period is very inefficient when using the scanning method where the required dosage can vary by two or more orders of magnitude. Hitachi s synchrotron can decelerate the remaining beam immediately after the required dosage has been extracted, dispose of the beam at low energy, and then accelerate the next beam. The accelerator s flat-top period can be varied between several milliseconds to five seconds with an associated operating cycle period of between two and nine seconds. By varying the time at each energy dynamically, this method avoids wasting time. This variable flat-top/variable cycle operation was developed as part of the respiration-synchronized operation technique for the synchrotron. Respirationsynchronized irradiation is a technique for improving the accuracy of irradiation by synchronizing the irradiation timing with the patient s breathing phase. It is used with scattering-method treatment of torso regions that move as the patient breathes. Hitachi developed variable flat-top/variable cycle operation for the proton therapy system supplied to the University of Tsukuba where it became the first accelerator in the world to achieve respirationsynchronized variable flat-top/variable cycle operation. The same technique is used effectively with the scanning method. Monitoring and Safety System Scanning irradiation requires highly accurate control of beam dose and beam position, and the monitoring and safety system that monitors these parameters plays an important role. The following sections describe the monitoring and safety functions associated with beam control. (1) Irradiation dose management As described earlier, the beam dosage is measured by the main dose monitor and beam on/off control is performed using this information. The beam turns off approximately 1 μs after a beam off signal is issued.

World-first Proton Pencil Beam Scanning System with FDA Clearance 23 The spot dose measured by the sub-dose monitor is compared with the treatment plan and irradiation is halted if the dose exceeds the plan by a specified fixed amount in case this indicates a fault in the beam shutdown function. The integrity of the dose monitors is also checked by comparing the ratio of outputs from the sub and main dose monitors. The spot irradiation time is also measured and irradiation is halted if this is abnormally long in case it indicates a fault in the dose measurement function or beam shutdown function. Together, this timer and the main and sub-dose monitors provide three dose monitoring functions. (2) Spot position management The beam position is controlled by the scanning magnets. While beam irradiation is in progress, the excitation current in the scanning magnets is monitored and irradiation halted if the current deviates from the set value by more than the allowed tolerance. The actual position through which the beam passes is measured and checked for each spot by the spot position monitor near the irradiation surface. Irradiation is halted if the deviation of the measured beam position from the plan value exceeds the allowed tolerance. The spot position monitor measures the beam size as well as its position and halts irradiation if the deviation from the plan value exceeds the allowed tolerance. This provides multiple monitoring functions for the beam position. (3) Beam energy check The beam energy is controlled and verified with a high level of accuracy by the synchrotron accelerator. The excitations of the bending magnets in the high-energy beam transport line used to deliver the extracted beam to the treatment rooms are also monitored in such a way as to prevent any beam arriving with the maladjusted energy from reaching the treatment rooms. (4) Irradiation pause and resume If any abnormality is detected, the beam is turned off immediately and treatment halted. Beam extraction can be turned off in 1 μs by turning off the high-frequency electric field used to extract the beam. Irradiation is reliably shut down by multiple methods, the others being turning off the beam supplied to the synchrotron by the injector linac and using the fast beam stopper, which can close in approximately.3 s, to block the beam transport path. Except in the case of a serious fault, treatment can be restarted again after it halts at the discretion of the operator. In this case, treatment restarts correctly from the spot after the spot for which treatment halted. SCANNING NOZZLE BEAM PERFORMANCE The following sections describe the beam performance based on data obtained from testing of the MDACC scanning nozzle. Spot Position Control Fig. 8 shows a plot of the deviation between the measured and planned spot positions for twodimensional scanning of a 3 cm 3 cm region of approximately 1, spots. The position error dy (cm).2.1.1.2.2.1.1.2 dx (cm) Fig. 8 Spot Position Control Performance (Two-dimensional Scanning). This plot of spot position error for two-dimensional scanning of approximately 1, spots using the MDACC scanning nozzle shows that the accuracy is within +/-.5 mm. Y (cm).2.1.1.2.2 deg. 9 deg. 18 deg. 27 deg..1.1.2 X (cm) Fig. 9 Spot Position Control Performance (Energy Scanning). This plot of spot position error for energy scanning of 47 energy levels using the MDACC scanning nozzle shows that the accuracy is within +/-.5 mm for all four irradiation directions.

Hitachi Review Vol. 58 (29), No.5 231 is within +/-.5 mm. Fig. 9 shows a plot of the spot positions for each energy for energy scanning operation covering 47 energy levels. The results from rotating the gantry beam to perform irradiation from four different angles are also plotted on the same graph and the position error is within +/-.5 mm under all conditions. These measurements verify that the beam position can be controlled with a very high level of accuracy. Volumetric Irradiation Fig. 1 shows an example measurement of an SOBP in the depth direction using 47 different energies. The result shows that a highly uniform dose distribution has been achieved over a depth range from 1 to 3 cm. Relative dose (%) Fig. 1 Uniform Distribution with Respect to Depth. These example measurements from the MDACC scanning nozzle indicate a uniform dose distribution in the depth direction. The results show a SOBP (spread out Bragg peak) with constant dose for depths from 1 cm to 3 cm. Relative dose (%) 12 1 8 6 4 2 12 1 8 6 4 2 Calculated Measured 5 1 15 2 25 3 35 Depth into water (cm) Fig. 11 shows an example distribution measurement on a radiation film for a uniform distribution over a 3 cm 3 cm lateral region. This demonstrates that a uniformity of +/- 3% can be achieved. Also, testing of dose reproducibility by repeatedly irradiating a 1-L region over a week demonstrated that a very high level of reproducibility could be achieved with variation of less than +/-.3%. CONCLUSIONS This article has described the scanning nozzle used by the proton therapy system supplied to the MDACC. The MDACC scanning system has received FDA (U.S. Food and Drug Administration) clearance and the first commercial scanning treatment commenced on May 19 28. Full handover of all facilities took place in September 28 and, together with the three scattering nozzles, the system is now treating more than 8 patients per day. The success of this project has greatly accelerated the move toward adopting scanning systems in proton therapy. Hitachi intends to continue contributing to the field of radiotherapy by pursuing even greater performance and by developing and supplying very safe and reliable systems. REFERENCES (1) K. Umegaki et al., Development of Advanced Proton Beam Therapy System for Cancer Treatment, Hitachi Review 52, pp. 196-21 (Dec. 23). (2) J. Hirota et al., System Design of Particle Accelerator, Hitachi Hyoron 79, pp. 211-216 (Feb. 1997) in Japanese. (3) K. Matsuda et al., Beam Commissioning of a Multi- Purpose Compact Ion Synchrotron, Proceedings of the 21 Particle Accelerator Conference, pp.259-2592 (June 21). (4) M. Umezawa, Beam Commissioning of the New Proton Therapy System for Univ. of Tsukuba, Proceedings of the 21 Particle Accelerator Conference, pp.648-65 (June 21). (5) K. Hiramoto and M. Nishi, Resonant Beam Extraction Scheme with Constant Separatrix, Nuclear Instruments and Methods in Physics Research, A322, pp.154-16 (1992). 2 1 Lateral position (mm) 1 2 Fig. 11 Dose Distribution in Lateral Direction. These example measurements obtained from the MDACC scanning nozzle using radiation film show a uniform distribution in the lateral direction and demonstrate a uniformity performance of +/-3%.

World-first Proton Pencil Beam Scanning System with FDA Clearance 232 ABOUT THE AUTHORS Koji Matsuda Joined Hitachi, Ltd. in 1993, and now works at the Medical Systems and Nuclear Equipment Division, Hitachi Works, Power Systems Company. He is currently engaged in the system design of particle irradiation systems. Mr. Matsuda is a member of the Japan Society of Medical Physics and the Physical Society of Japan. Hiroyuki Itami Joined Hitachi, Ltd. in 1991, and now works at the Medical Systems and Nuclear Equipment Division, Hitachi Works, Power Systems Company. He is currently engaged in preventative maintenance planning and project management for particle irradiation systems. Daishun Chiba Joined Hitachi, Ltd. in 1995, and now works at the Nuclear Power Control and Instrumentation Systems Engineering Department, Information & Control Systems Company. He is currently engaged in the design of human machine interfaces for particle irradiation systems. Kazuyoshi Saito, Dr. Eng. Joined Hitachi, Ltd. in 1989, and now works at the Medical System Project, Energy & Environmental Systems Laboratory, Power Systems Company. He is currently engaged in the development of accelerator systems and their radio-frequency devices for particle beam therapy. Dr. Saito is a member of the Particle Accelerator Society of Japan.